ARIZ Precision Medicine is a pioneering brand at the forefront of drug development. Our mission is to design drugs that have the power to be curative through the innovative practice of Precision Medicine. By modulating PRDM genes and proteins and incorporating key Precision Medicine components, we are revolutionizing the way drugs are developed and administered.

Our product platform is built on a foundation of small interfering ribonucleic acids (siRNA), which specifically target and destroy cancer cell driver proteins without harming healthy cells. We have also developed targeting peptides that guide our drug delivery systems exclusively to cancer cells. By utilizing the most effective nanoparticles and incorporating PEG, we are able to protect and concentrate the drug precisely where it is needed.

Significantly, our research is centered around the PRDM family of proteins, which play a fundamental role in regulating thousands of genes and proteins involved in cell growth, proliferation, migration, and survival. By understanding and manipulating these proteins, we aim to suppress tumor growth and ensure better outcomes for cancer patients. ARIZ Precision Medicine is committed to innovation, evidenced by our extensive patent portfolio covering PRDM genes and proteins, as well as the composition, utility, and production of our products.

Join us on our mission to revolutionize drug development and improve the lives of cancer patients. Contact us for further information